Pangaea Oncology, S.A. (BME:PANG)

Pangaea Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 28, 2026	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	62	54	50	35	27	29
Market Cap Growth	7.68%	8.35%	41.34%	30.94%	-5.88%	-1.37%
Enterprise Value	65	52	40	35	30	32
Last Close Price	1.72	1.84	1.64	1.55	1.58	1.68
Forward PE	-	97.14	97.14	-	-	-
PS Ratio	4.33	5.44	7.49	5.27	4.38	5.22
PB Ratio	3.67	2.88	2.17	2.51	3.25	3.45
P/TBV Ratio	6.06	4.88	2.39	1.69	4.11	4.55
PEG Ratio	-	2.74	2.74	8.85	-	-
EV/Sales Ratio	4.52	5.18	6.00	5.25	4.87	5.83
Debt / Equity Ratio	0.23	0.18	0.11	0.25	0.52	0.45
Net Debt / Equity Ratio	0.12	0.03	-0.26	0.04	0.38	0.27
Net Debt / EBITDA Ratio	-0.63	-0.22	2.63	-2.30	-2.10	-1.00
Net Debt / FCF Ratio	-0.70	-0.22	1.65	-0.24	-1.59	-0.92
Asset Turnover	0.55	0.35	0.27	0.36	0.37	0.30
Inventory Turnover	3.84	5.05	5.96	3.38	4.28	3.74
Quick Ratio	1.04	1.27	4.74	2.20	1.09	0.97
Current Ratio	1.16	1.34	4.89	2.36	1.19	1.02
Return on Equity (ROE)	-29.97%	-22.89%	-14.66%	-5.73%	-21.09%	-57.57%
Return on Assets (ROA)	-9.44%	-7.52%	-6.85%	-2.12%	-6.96%	-8.86%
Return on Invested Capital (ROIC)	-20.84%	-18.92%	-17.01%	-4.90%	-17.15%	-24.01%
Return on Capital Employed (ROCE)	-20.10%	-15.90%	-10.50%	-3.60%	-15.30%	-22.20%
Earnings Yield	-8.59%	-8.59%	-5.42%	-1.81%	-6.49%	-16.86%
FCF Yield	-4.66%	-4.90%	-7.39%	-7.14%	-7.35%	-8.35%
Buyback Yield / Dilution	-3.35%	0.98%	-35.11%	-20.34%	-10.89%	-28.80%

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.